649550-97-0 Usage
General Description
6-Fluoro-1H-indole-3-carboxylic acid methyl ester is a chemical compound frequently used in various research and industrial applications. 6-Fluoro-1H-indole-3-carboxylic acid methyl ester, which belongs to the class of organic compounds known as indoles, contains a distinctive indole core structure, which consists of a bicyclic structure made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. The methyl ester refers to a part of the compound that includes a methyl group (-CH3) attached to the carboxylic acid portion of the molecule. The 6-fluoro designation indicates that a fluorine atom is attached at the 6th position of the indole structure. It is known for its reactivity and potential use in the synthesis of complex molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 649550-97-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,9,5,5 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 649550-97:
(8*6)+(7*4)+(6*9)+(5*5)+(4*5)+(3*0)+(2*9)+(1*7)=200
200 % 10 = 0
So 649550-97-0 is a valid CAS Registry Number.
649550-97-0Relevant articles and documents
Application of new cryptolepine derivatives in controlling and preventing plant-derived germs
-
Paragraph 0013-0017; 0032-0034, (2019/01/14)
The invention relates to the technical field of natural medicinal chemistry and biopesticide, and discloses application of any one compound of 1a-24a of new cryptolepine derivatives in the preparationof a medicament for controlling or resisting rice blast
3-GUANIDINOCARBONYL-1-HETEROARYL-INDOLE DERIVATIVES, PREPARATION PROCESS, THEIR USE AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
-
Page 45, (2008/06/13)
The present invention relates to 3-guanidinocarbonyl-1-heteroaryl-indole derivatives of the formula (I) in which R1 to R5 and Ar have the meaning stated in the claims. The inventive compounds are suitable for example as antiarrhytmic medicaments with cardioprotective component for infarction prophylaxis and infarction treatment and for the treatment of angina pectoris. They also inhibit in a preventive manner the pathophysiological processes associated with the development of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhytmias and of heart failure.
